Suraj Kalia
Stock Analyst at Oppenheimer
(3.12)
# 1,273
Out of 5,102 analysts
86
Total ratings
46.58%
Success rate
12.72%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Outperform | $175 | $137.37 | +27.39% | 3 | Dec 8, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $23 → $18 | $11.76 | +53.06% | 7 | Nov 19, 2025 | |
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $84.24 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $36.03 | +66.53% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $13.75 | +60.00% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $127.62 | +17.54% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $41.42 | +8.64% | 7 | Feb 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $169.10 | -29.04% | 6 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $45.48 | -29.64% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $83.36 | +11.56% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $130 | $123.28 | +5.45% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $7.50 | +33.33% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $4.87 | +166.94% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $72.34 | +86.62% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $252.39 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $28.23 | +6.27% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $1.10 | +18,081.82% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $86.05 | +12.73% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $24.88 | +12.54% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $3.08 | +46.10% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.31 | +1,121.37% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $547.36 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $1.84 | +35,769.57% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $3.34 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $18.90 | +429.10% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $68.94 | - | 5 | Sep 12, 2018 |
Inspire Medical Systems
Dec 8, 2025
Upgrades: Outperform
Price Target: $175
Current: $137.37
Upside: +27.39%
Varex Imaging
Nov 19, 2025
Maintains: Outperform
Price Target: $23 → $18
Current: $11.76
Upside: +53.06%
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $84.24
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.03
Upside: +66.53%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $13.75
Upside: +60.00%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $127.62
Upside: +17.54%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $41.42
Upside: +8.64%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $169.10
Upside: -29.04%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $45.48
Upside: -29.64%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $83.36
Upside: +11.56%
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $123.28
Upside: +5.45%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $7.50
Upside: +33.33%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $4.87
Upside: +166.94%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $72.34
Upside: +86.62%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $252.39
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $28.23
Upside: +6.27%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $1.10
Upside: +18,081.82%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $86.05
Upside: +12.73%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $24.88
Upside: +12.54%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $3.08
Upside: +46.10%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.31
Upside: +1,121.37%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $547.36
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $1.84
Upside: +35,769.57%
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $3.34
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $18.90
Upside: +429.10%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $68.94
Upside: -